• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2013 Fiscal Year Final Research Report

Development of novel drugs for heart failure treatment based on modulating kinase activity of cardiac-MLCK

Research Project

  • PDF
Project/Area Number 24790792
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Circulatory organs internal medicine
Research InstitutionNational Cardiovascular Center Research Institute

Principal Investigator

SEGUCHI Osamu  独立行政法人国立循環器病研究センター, 病院, 医師 (60570869)

Co-Investigator(Renkei-kenkyūsha) KITAKAZE Masafumi  独立行政法人国立循環器病研究センター, 臨床研究開発基盤センター, 部長 (20294069)
TAKASHIMA Seiji  大阪大学, 大学院医学系研究科医化学講座, 教授 (90379272)
Project Period (FY) 2012-04-01 – 2014-03-31
Keywords心不全 / 心筋症 / 遺伝子 / リン酸化酵素 / ペプチド創薬
Research Abstract

The aim of this study is to develop novel drugs for heart failure which is increasing yearly in aging society of Japan.
We have previously identified novel cardiac-specific myosin light chain kinase (cardiac-MLCK) which is closely associated with the pathophysiology of heart failure. Recently, we also identified 8 unique peptide drugs suppressing kinase activity of cardiac-MLCK and we are investigating the pharmacologic effects of the peptide drugs for heart. These peptide drugs are expecting to become preventing drugs for heart failure through treating pathologic cardiac hypertrophy.

  • Research Products

    (1 results)

All Other

All Remarks (1 results)

  • [Remarks] 研究会発表平成25年度Vascular Biology Innovation Conference 題名「心臓型MLCKと心不全、心筋症との関わり」

URL: 

Published: 2015-06-25  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi